Mehdi Hamadani

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ADC Therapeutics, Omeros, CRISPR, BMS, Kite, AbbVie, Caribou, Genmab.
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    ADC Therapeutics, AstraZeneca, Bei Gene, Kite.
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility